Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • Archive
    • Minireviews
    • JB Special Collection
    • JB Classic Spotlights
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JB
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Journal of Bacteriology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • Archive
    • Minireviews
    • JB Special Collection
    • JB Classic Spotlights
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JB
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
GENETICS AND MOLECULAR BIOLOGY

Induction of Prophages of EnterohemorrhagicEscherichia coli O157:H7 with Norfloxacin

Aizo Matsushiro, Koki Sato, Hiroshi Miyamoto, Tadashi Yamamura, Takeshi Honda
Aizo Matsushiro
The School of Biology-Oriented Science and Technology, Department of Molecular Genetics, Kinki University, Wakayama 649-6493, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Koki Sato
The School of Biology-Oriented Science and Technology, Department of Molecular Genetics, Kinki University, Wakayama 649-6493, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hiroshi Miyamoto
The School of Biology-Oriented Science and Technology, Department of Molecular Genetics, Kinki University, Wakayama 649-6493, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tadashi Yamamura
The School of Biology-Oriented Science and Technology, Department of Molecular Genetics, Kinki University, Wakayama 649-6493, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Takeshi Honda
The Research Institute for Microbial Diseases, Osaka University, Suita, Osaka 565-0871, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/JB.181.7.2257-2260.1999
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

Norfloxacin (NFLX) caused induction of prophages VT1 and VT2 of enterohemorrhagic Escherichia coli O157 at subinhibitory concentrations. In time course experiments, we observed the following sequential events: upon induction, the phage genomes underwent multiplication; the amount of stx genes increased; and subsequently, large quantities of toxins VT1 and VT2 were produced. Further studies showed that the molecular mechanism of prophage induction is closely related to the RecA system since the prophage VT2 was not induced with NFLX in a recA mutant strain.

In the summer of 1996 in Japan, large outbreaks of enterohemorrhagic Escherichia coli (EHEC) O157:H7 infection took place, especially in Sakai City, Osaka Prefecture. Many school children, totalling thousands of cases, suffered from diarrhea and hemorrhagic colitis, and some developed hemolytic-uremic syndrome (HUS) characterized by acute renal failure, thrombocytopenia, and microangiopathic hemolytic anemia, resulting in 12 deaths. Mechanisms causing the above conditions have been investigated from various aspects. Vero toxin (VT) (4, 17) and other possible virulence factors of EHEC O157 (8, 11, 12) and directions for the use of drugs, especially antimicrobial agents, are also being re-evaluated. The 1997 guideline for medical treatment of EHEC O157 infection issued by the Ministry of Health and Welfare in Japan (13) has recommended the use of kanamycin, fosfomycin, and a new quinolone antimicrobial agent, norfloxacin (NFLX). However, Walterspiel et al. (22) reported that, instead, these various antimicrobial agents, including the new quinolone, induced the production of VT under certain conditions. Thus, to solve the apparent contradictions, we have started to investigate the induction of the prophage carrying the stx gene by NFLX. In this communication, we show that NFLX indeed induces thestx-converting phages and suggest the following underlying mechanism: NFLX is an inhibitor specific for the A subunit of DNA gyrase (7, 23), the drug inhibits DNA synthesis in E. coli and causes an accumulation of single-stranded DNA fragments capable of activating the RecA protein (2, 18), and the activated RecA protein promotes the cleavage of a phage repressor, allowing prophage induction (2, 19). Thus, as a result of this process, the phage in vegetative growth starts VT phage DNA replication and toxin production.

NFLX triggers prophage induction.We have examined whether NFLX could cause prophage induction, resulting in multiplication of stx genes and mass production of VT. Experiments were performed with EHEC O157 strain RIMD0509894. This strain, isolated during the EHEC outbreak in Sakai City in 1996 and provided by the Research Center for Emerging Infectious Diseases of Osaka University, was doubly lysogenic for phages VT1 and VT2, designated VT1-Sa and VT2-Sa, respectively. Overnight cultures in Luria-Bertani broth were subcultured by shaking for 1 h to the early logarithmic growth phase. They were treated with various subinhibitory concentrations of NFLX (provided by Kyorin Pharmaceuticals, Inc.) for prophage induction for 30 min, centrifuged, resuspended in drug-free Luria-Bertani broth, and subsequently cultured for phage growth and toxin production for a further 2 h. Infective-center assays were carried out by plating cells within a few minutes after induction together with the indicator E. coliK-12 W3110, which is nonlysogenic for λ, and on the following day, the plaques that appeared were counted. In the experiment, the efficiency of prophage induction corresponded to the number of infective centers divided by the number of plated induced cells. The number of infective centers increased with the concentration of NFLX up to 1 μg/ml and then declined (Fig. 1a). In parallel with prophage induction, production of two toxins, VT1 and VT2, showed patterns similar to that of prophage induction, although the level of VT2 was always higher than that of VT1 (Fig. 1b). These results indicated that both the infective centers and the toxin amount produced increased 100- to ∼1,000-fold in the presence of subinhibitory concentrations (0.1 to 10 μg/ml) of NFLX compared to those found in the absence of the drug and that those obtained with NFLX (1 μg/ml, 30 min) were almost same as those obtained with an optimal dose of UV light irradiation (1.66 J/m2, 30 s) (Fig. 1a).

Fig. 1.
  • Open in new tab
  • Download powerpoint
Fig. 1.

Prophage induction in EHEC O157 strain RIMD0509894. (a) Efficiency of prophage induction (closed circles, NFLX; open circle, application of UV light for 30 s). The assay was performed as described in the text. Since this strain is a double lysogen for phages VT1 and VT2, infective centers contain both phages. (b) Toxin production. For assay of toxins, E. coli cultures, after incubation for 2 h, were centrifuged at 5,000 × g for 5 min. The amounts of VT1 and VT2 in the supernatants were then separately determined by using a reversed passive latex agglutination test kit (E. coli Verotoxin Detection Kit; Denka Seiken Co., Tokyo, Japan) as described in the manufacturer’s manual.

Time course analysis after induction.Figure2 illustrates results of time course experiments with EHEC strain RIMD0509894. After induction, toxin production and synthesis of stx-specific DNA were monitored. All of these values increased 10- to ∼100-fold with time and reached plateaus after 60 to 90 min. In this experiment, we employed the probe specific for VT1 or VT2, neither of which cross-hybridized with the other. When a probe of the other fragment derived from VT2 phage, which was irrelevant to the stx DNA was used, essentially the same results were obtained (data not shown). Thus, the increase in the stx gene indicated replication of the phage DNA. Concerning the two kinds of VT in this strain, VT1-Sa and VT2-Sa, a difference of 1 order of magnitude between the production of VT1 and that of VT2 was observed, production of VT2 being higher than that of VT1. This result was consistent with the observation that the synthesized amounts of the DNAs encoding these toxins also differed by roughly 1 order of magnitude. Since the copy numbers of prophages VT1 and VT2 per genome were identical to each other, the growth of phage VT2 should be much faster than that of VT1.

Fig. 2.
  • Open in new tab
  • Download powerpoint
Fig. 2.

Time course experiments using EHEC O157 strain RIMD0509894. Panels: a, toxins VT1 and VT2; b, VT1- and VT2-specific DNAs. The VT1 and VT2 toxin DNA assay method used is as follows. After induction for 30 min with 1-μg/ml NFLX, 1-μl aliquot of a culture was spotted onto each of two nitrocellulose filters (Nitroplus 2000; Micron Separations Inc., Westborough, Mass.) every 30 min. One filter was hybridized with fluorescein-labeled fragments containing VT1 gene DNA (100 ng), and the other was hybridized with VT2 gene DNA in 10 ml of 6× SSC (1× SSC is 0.15 M NaCl plus 0.015 M sodium citrate)–5× Denhardt’s solution–0.5% sodium dodecyl sulfate–4 mM EDTA–100-μg/ml salmon sperm DNA. After being washed in 0.5× SSC at 60°C, the filter was incubated with an anti-fluorescein–alkaline phosphatase conjugate and visualized with the fluorescence substrate Atto Phos (Amersham Pharmacia Biotech, Ltd., Uppsala, Sweden). The fluorescence signals were detected with a FluorImager (Molecular Dynamics Inc., Sunnyvale, Calif.). The amount of VT1- and VT2-specific DNA was expressed in arbitrary fluorescence intensity units as measured at 540 to 560 nm (excitation at 488 nm).

Concerning toxin gene multiplication and toxin protein production after prophage induction, the following two points are worth mentioning. Firstly, we have determined the complete nucleotide sequence of phage VT2-Sa. This result (14) and recent reports (3, 16) have together demonstrated, through a search for sequence homology between VT2-Sa and phage λ, that the stx gene is located downstream of the Q gene homologue and upstream of the homologues of the S and R genes encoding lytic enzymes. This indicates that the stx gene is likely transcribed from the pR′ promoter as a part of late gene expression under the influence of the Q gene product synthesized after inactivation of the phage repressor (6, 16, 20). We observed that from 90 to 120 min after induction with NFLX, phage maturation and the subsequent burst were always accompanied by complete cell lysis (data not shown). These results led to the following conclusion: NFLX causes prophage induction, resulting in an increase in the copy number and transcription of the stxgene and cell lysis-mediated massive toxin release.

Secondly, we further confirmed the toxin production by using a different strain. We have examined VT1-Sa and VT2-Sa from strain RIMD0509894, which was isolated during the outbreak in Sakai City in 1996. Another EHEC O157:H7 strain, V141, which is singly lysogenic for VT2 and was isolated in Tokyo by Tae Takeda in 1996, is known to produce phage VT2-141, which has immunity different from that of VT2-Sa. Analyses of these strains indicated that the two strains have similar patterns of prophage induction by NFLX, as well as similar time course profiles for stx gene multiplication and VT production. Thus, induction of the toxin-converting phage by NFLX appears to be a general phenomenon.

Mitomycin-induced increases in toxin production were reported in EHEC H18 (O128:H12) (15, 24) and Shigella species (21). However, in these cases, the stx gene was located on the host chromosome. Some of these cases may be accounted for by the heteroimmune induction by prophages other than the toxin-converting phages.

RecA protein plays a key role in prophage induction.VT2-Sa single lysogens were prepared by spotting phage VT2-Sa on lawns of E. coli K-12 W3110recA+ and isogenic recA mutant strains and verified by PCR with primers based on a part of the VT2 gene sequence. These lysogens were examined for prophage induction, and the results are shown in Fig. 3. An increase in VT2 toxin DNA was observed after induction in therecA+ strain but not in the recAmutant strain. These results indicated a crucial role of RecA protein in VT2 prophage induction.

Fig. 3.
  • Open in new tab
  • Download powerpoint
Fig. 3.

Induction with NFLX of E. coli K-12 W3110recA+ and recA mutant strains both singly lysogenic for VT2-Sa. Curves: a, VT2-specific DNA synthesized in the recA+ strain (VT2-Sa); b, VT2-specific DNA synthesized in the recA mutant (VT2-Sa); c, VT2-specific DNA synthesized in the presence of NFLX.

stx-specific DNA synthesis in therecA+ lysogen was also examined in the continued presence of NFLX (Fig. 3c). However, under these conditions, neither toxin gene multiplication nor toxin protein synthesis took place. It was concluded that NFLX not only triggers prophage induction but also inhibits DNA synthesis of the toxin genes in its continued presence. Hence, continued inhibition of DNA synthesis in the bacteria and phages leads to abrogation of toxin production. However, it should be pointed out that although NFLX is effective for treatment of O157 infection, discontinuation of medication halfway in the course of treatment may occasionally stimulate toxin production. This conclusion should be a useful guideline for the medical treatment of EHEC O157 infection.

As far as we have determined, of the antimicrobial agents available, only an inhibitor of peptidoglycan synthesis, fosfomycin, and an inhibitor of protein synthesis, kanamycin, have not caused any increase in toxin production. In contrast, DNA synthesis inhibitors such as the new quinolones trimethoprim (9) and mitomycin C (1, 24) have been reported to augment toxin production by various EHEC strains in vitro, as well as in vivo. A high incidence of cancer-associated HUS after mitomycin treatment (5, 10) could be related to such toxin production.

As described in this report, the relative amount of VT produced by noninduced cells was less than 10−3 compared with that produced by induced cells. Release of toxin proteins in large quantities outside the cell may be due to a burst of phage-mediated lytic-enzyme released by E. coli. However, every case of HUS is not necessarily brought about by antimicrobial agents; there must also be some inducers or triggers in the intestinal lumen that cause serious systemic toxin-related complications like HUS.

ACKNOWLEDGMENTS

We thank Tae Takeda and Akiko Nishimura for generously giving us bacterial strains. We also thank Yoshinobu Sugino, Laboratory of Molecular Biology, Kansai Medical University, for helpful discussions and Akio Tanaka for critical reading of the manuscript.

FOOTNOTES

    • Received 8 July 1998.
    • Accepted 25 January 1999.
  • Copyright © 1999 American Society for Microbiology

REFERENCES

  1. 1.↵
    1. Al-Jumaili I.,
    2. Burke D. A.,
    3. Scotland S. M.,
    4. Al-Mardini H. M.,
    5. Record C. O.
    A method of enhancing verocytotoxin production by Escherichia coli.FEMS Microbiol. Lett.931992121126
    OpenUrlCrossRef
  2. 2.↵
    1. Craig N. L.,
    2. Roberts J. W.
    E. coli recA protein-directed cleavage of phage λ repressor requires polynucleotide.Nature28319802630
    OpenUrlCrossRefPubMedWeb of Science
  3. 3.↵
    1. De Grandis S.,
    2. Ginsberg J.,
    3. Toone M.,
    4. Climie S.,
    5. Friesen J.,
    6. Brunton J.
    Nucleotide sequence and promoter mapping of the Escherichia coli Shiga-like toxin operon of bacteriophage H-19B.J. Bacteriol.169198743134319
    OpenUrlAbstract/FREE Full Text
  4. 4.↵
    1. Endo Y.,
    2. Tsurugi K.,
    3. Yutsudo T.,
    4. Takeda Y.,
    5. Ogasawara T.,
    6. Igarashi K.
    Site of action of a Vero toxin (VT2) from Escherichia coli O157: H7 and of Shiga toxin on eukaryotic ribosomes RNA N-glycosidase activity of the toxins.Eur. J. Biochem.17119884550
    OpenUrlCrossRefPubMedWeb of Science
  5. 5.↵
    1. Hanna W. T.,
    2. Kraus S.,
    3. Regestger R. F.,
    4. Murphy W. M.
    Renal disease after mitomycin C therapy.Cancer48198125832588
    OpenUrlCrossRefPubMedWeb of Science
  6. 6.↵
    1. Herskowitz I.,
    2. Signer E.
    A site essential for expression of all late genes in bacteriophage lambda.J. Mol. Biol.471970545556
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. Hirai K.,
    2. Aoyama H.,
    3. Suzue S.,
    4. Irikura T.,
    5. Iyobe S.,
    6. Mitsuhashi S.
    Isolation and characterization of norfloxacin-resistant mutants of Escherichia coli K-12.Antimicrob. Agents Chemother.301986248253
    OpenUrlAbstract/FREE Full Text
  8. 8.↵
    1. Ismaili A.,
    2. Philpott D. J.,
    3. Dytoc M. T.,
    4. Sherman P. M.
    Signal transduction responses following adhesion of verocytotoxin-producing Escherichia coli.Infect. Immun.63199533163326
    OpenUrlAbstract/FREE Full Text
  9. 9.↵
    1. Karch H.,
    2. Strockbine N. A.,
    3. O’Brien A. D.
    Growth of Escherichia coli in the presence of trimethoprim-sulfamethoxazole facilitates detection of Shiga-like toxin producing strains by colony blot assay.FEMS Microbiol. Lett.351986141145
    OpenUrlCrossRef
  10. 10.↵
    1. Lesene J. B.,
    2. Rothschild N.,
    3. Erickson B.,
    4. Korec S.,
    5. Sisk R.,
    6. Keller J.,
    7. Arbus M.,
    8. Woolley P. V.,
    9. Chiazze L.,
    10. Schein P. S.,
    11. Neefe J. R.
    Cancer-associated hemolytic-uremic syndrome: an analysis of 85 cases from a National Registry.J. Clin. Oncol.71989781789
    OpenUrlAbstract
  11. 11.↵
    1. Makino K.,
    2. Ishii K.,
    3. Yasunaga T.,
    4. Hattori M.,
    5. Yokoyama K.,
    6. Yutsudo C. H.,
    7. Kubota Y.,
    8. Yamaichi Y.,
    9. Iida T.,
    10. Yamamoto K.,
    11. Honda T.,
    12. Han C.-G.,
    13. Ohtsubo E.,
    14. Kasamatsu M.,
    15. Hayashi T.,
    16. Kuhara S.,
    17. Shinagawa H.
    Complete nucleotide sequences of 93-kb and 3.3-kb plasmids of an enterohemorrhagic Escherichia coli O157:H7 derived from Sakai outbreak.DNA Res.5199819
    OpenUrlCrossRefPubMed
  12. 12.↵
    1. McDaniel T. K.,
    2. Jarvis K. G.,
    3. Donnenberg M. S.,
    4. Kaper J. B.
    A genetic locus of enterocyte effacement conserved among diverse entero-bacterial pathogens.Proc. Natl. Acad. Sci. USA92199516641668
    OpenUrlAbstract/FREE Full Text
  13. 13.↵
    Ministry of Health and Welfare, Japan The guideline on the treatment of O157 infection for primary and secondary medical facilities (The Research Group on Diagnosis and Treatment of Enterohemorrhagic Escherichia coli Infection; group leader, Yoshifumi Takeda).Jpn. J. Bacteriol.51199610961098 (In Japanese.)
    OpenUrl
  14. 14.↵
    1. Miyamoto H.,
    2. Nakai W.,
    3. Yazima N.,
    4. Matsushiro A.
    Complete nucleotide sequence of stx-converting phage VT2 of an EHEC O157 The Second Workshop of the Frontier Genome Research on Microorganisms 1999 33Osaka, Japan.
  15. 15.↵
    1. Mühldorfer I.,
    2. Hacker J.,
    3. Keuach G. T.,
    4. Acheson D. W.,
    5. Tschäpe H.,
    6. Kane A. V.,
    7. Ritter A.,
    8. Ölschläger T.,
    9. Donohue-Rolfe A.
    Regulation of the Shiga-like toxin II operon in Escherichia coli.Infect. Immun.641996495502
    OpenUrlAbstract/FREE Full Text
  16. 16.↵
    1. Neely M. N.,
    2. Friedman D. I.
    Functional and genetic analysis of regulatory regions of coliphage H-19B: location of shiga-like toxin and lysis genes suggest a role for phage functions in toxin release.Mol. Microbiol.28199812551267
    OpenUrlCrossRefPubMedWeb of Science
  17. 17.↵
    1. O’Brien A. D.,
    2. Tesh V. L.,
    3. Donohue-Rolfe A.,
    4. Jachson M. P.,
    5. Olsnes S.,
    6. Sandrig K.,
    7. Lindberg A. A.,
    8. Keusch G. T.
    Pathogenesis of shigellosis: Shiga toxin: biochemistry, genetics, mode of action and role in pathogenesis.Curr. Top. Microbiol. Immunol.18019926594
    OpenUrlPubMedWeb of Science
  18. 18.↵
    1. Ogawa T.,
    2. Wabiko H.,
    3. Tsurimoto T.,
    4. Horii T.,
    5. Matsukata H.,
    6. Ogawa H.
    Characteristics of purified recA protein and the regulation of its synthesis in vivo.Cold Spring Harbor Symp. Quant. Biol.431978909915
    OpenUrl
  19. 19.↵
    1. Roberts J. W.,
    2. Roberts C. W.,
    3. Craig N. L.
    Escherichia coli recA gene product inactivates phage lambda repressor.Proc. Natl. Acad. Sci. USA75197847144718
    OpenUrlAbstract/FREE Full Text
  20. 20.↵
    1. Sato K.,
    2. Campbell A.
    Specialized transduction of galactose by lambda phage from a deletion lysogen.Virology411970474487
    OpenUrlCrossRefPubMed
  21. 21.↵
    1. Takeda Y.,
    2. Okamoto K.,
    3. Miwatani T.
    Mitomycin C stimulates production of a toxin in Shigella species that causes morphological changes in Chinese hamster ovary cells.Infect. Immun.231979178180
    OpenUrlAbstract/FREE Full Text
  22. 22.↵
    1. Walterspiel J. N.,
    2. Ashkenazi S.,
    3. Morrow A. L.,
    4. Cleary T. G.
    Effect of subinhibitory concentration of antibiotics on extra-cellular Shiga-like toxin I.Infection2019922529
    OpenUrlCrossRefPubMedWeb of Science
  23. 23.↵
    1. Willmott C. J.,
    2. Maxwell A.
    A single point mutation in the DNA gyrase A protein greatly reduces binding of fluoroquinolones to the gyrase-DNA complex.Antimicrob. Agents Chemother.371993126127
    OpenUrlAbstract/FREE Full Text
  24. 24.↵
    1. Yee A. J.,
    2. De Grandis S.,
    3. Gyles C. L.
    Mitomycin-induced synthesis of a Shiga-like toxin from enteropathogenic Escherichia coli H.I.8.Infect. Immun.61199345104513
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top
Download PDF
Citation Tools
Induction of Prophages of EnterohemorrhagicEscherichia coli O157:H7 with Norfloxacin
Aizo Matsushiro, Koki Sato, Hiroshi Miyamoto, Tadashi Yamamura, Takeshi Honda
Journal of Bacteriology Apr 1999, 181 (7) 2257-2260; DOI: 10.1128/JB.181.7.2257-2260.1999

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Journal of Bacteriology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Induction of Prophages of EnterohemorrhagicEscherichia coli O157:H7 with Norfloxacin
(Your Name) has forwarded a page to you from Journal of Bacteriology
(Your Name) thought you would be interested in this article in Journal of Bacteriology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Induction of Prophages of EnterohemorrhagicEscherichia coli O157:H7 with Norfloxacin
Aizo Matsushiro, Koki Sato, Hiroshi Miyamoto, Tadashi Yamamura, Takeshi Honda
Journal of Bacteriology Apr 1999, 181 (7) 2257-2260; DOI: 10.1128/JB.181.7.2257-2260.1999
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Coliphages
Escherichia coli O157
Norfloxacin
Virus Activation

Related Articles

Cited By...

About

  • About JB
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #Jbacteriology

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0021-9193; Online ISSN: 1098-5530